Total Payments
$1,800
2024 Payments
$363.53
Companies
13
Transactions
84
Medicare Patients
474
Medicare Billing
$68,516
Payment Breakdown by Category
Food & Beverage$1,785 (99.2%)
Education$15.00 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,785 | 83 | 99.2% |
| Education | $15.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $629.60 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $314.47 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $227.62 | 11 | $0 (2024) |
| GENZYME CORPORATION | $212.69 | 12 | $0 (2024) |
| OptiNose US, Inc. | $109.16 | 2 | $0 (2019) |
| PFIZER INC. | $90.53 | 5 | $0 (2024) |
| Genentech USA, Inc. | $64.11 | 3 | $0 (2020) |
| ALK-Abello, Inc | $44.49 | 2 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $38.56 | 2 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $21.92 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $363.53 | 17 | AstraZeneca Pharmaceuticals LP ($194.09) |
| 2023 | $535.20 | 26 | AstraZeneca Pharmaceuticals LP ($250.42) |
| 2022 | $288.90 | 14 | AstraZeneca Pharmaceuticals LP ($95.18) |
| 2021 | $200.42 | 9 | GlaxoSmithKline, LLC. ($90.81) |
| 2020 | $85.60 | 5 | GlaxoSmithKline, LLC. ($30.69) |
| 2019 | $213.61 | 7 | OptiNose US, Inc. ($109.16) |
| 2018 | $73.78 | 4 | PFIZER INC. ($33.14) |
| 2017 | $38.56 | 2 | Teva Pharmaceuticals USA, Inc. ($38.56) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/28/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Immunology | ||||||
| 07/12/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Respiratory | ||||||
| 06/28/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Inflammation & Immunology | ||||||
| 05/13/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Respiratory | ||||||
| 05/12/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $12.73 | General |
| Category: Dermatology | ||||||
| 03/04/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Respiratory | ||||||
| 01/07/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Respiratory | ||||||
| 12/06/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Respiratory | ||||||
| 10/26/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.80 | General |
| 09/24/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/13/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: GENETIC DISEASE | ||||||
| 01/19/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/14/2021 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 11/19/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Respiratory | ||||||
| 10/29/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2020 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Immunology | ||||||
| 01/16/2020 | ALK-Abello, Inc | Odactra (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Allergy and Immunology | ||||||
| 08/28/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Immunology | ||||||
| 07/31/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Respiratory | ||||||
| 06/19/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 136 | 957 | $38,191 | $18,260 |
| 2022 | 4 | 118 | 1,029 | $37,228 | $18,030 |
| 2021 | 4 | 120 | 1,059 | $34,413 | $18,130 |
| 2020 | 4 | 100 | 1,138 | $30,158 | $14,096 |
Total Patients
474
Total Services
4,183
Medicare Billing
$68,516
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 27 | 433 | $8,650 | $5,611 | 64.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 54 | $9,720 | $4,840 | 49.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 32 | 432 | $12,096 | $4,092 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,075 | $2,993 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,650 | $723.53 | 43.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 30 | 473 | $9,450 | $6,720 | 71.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 57 | $10,260 | $4,763 | 46.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 32 | 481 | $13,468 | $4,491 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,050 | $2,057 | 50.8% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 33 | 518 | $10,350 | $7,526 | 72.7% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 33 | 471 | $13,188 | $4,286 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 51 | $6,600 | $4,027 | 61.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $4,275 | $2,291 | 53.6% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 34 | 578 | $11,050 | $7,431 | 67.2% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 44 | 536 | $15,008 | $4,437 | 29.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $2,475 | $1,287 | 52.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 13 | $1,625 | $941.47 | 57.9% |
About Dr. Eugene Tsai, MD
Dr. Eugene Tsai, MD is a Allergy & Immunology healthcare provider based in Artesia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053301200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Tsai, MD has received a total of $1,800 in payments from pharmaceutical and medical device companies, with $363.53 received in 2024. These payments were reported across 84 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,785).
As a Medicare-enrolled provider, Tsai has provided services to 474 Medicare beneficiaries, totaling 4,183 services with total Medicare billing of $68,516. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Artesia, CA
- Active Since 10/27/2005
- Last Updated 12/07/2007
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1053301200
Products in Payments
- FASENRA (Biological) $490.59
- DUPIXENT (Biological) $462.23
- NUCALA (Biological) $298.87
- Xhance (Drug) $109.16
- Xolair (Biological) $64.11
- FASENRA (Drug) $51.47
- Odactra (Drug) $44.49
- QVAR (Drug) $38.56
- CIBINQO (Drug) $38.23
- EUCRISA (Drug) $33.14
- BREZTRI (Drug) $31.88
- TEZSPIRE (Biological) $22.71
- TAKHZYRO (Biological) $21.86
- PANZYGA (Biological) $19.16
- AIRSUPRA (Drug) $16.15
- TRELEGY ELLIPTA (Drug) $15.60
- OPZELURA (Drug) $12.73
- ADBRY (Biological) $11.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.